Difference between revisions of "Team:Linkoping Sweden/Description"

 
(9 intermediate revisions by 2 users not shown)
Line 18: Line 18:
 
 
 
<Article class="flex-text-100">
 
<Article class="flex-text-100">
<h1> Project description</h1>
+
<h1> Project Description</h1>
 
<hr>
 
<hr>
 
</article>
 
</article>
Line 25: Line 25:
 
<article class="flex-text-70">
 
<article class="flex-text-70">
 
<p>
 
<p>
The aim of the project is to optimize the expression of the proteins amyloid-beta and tau in the bacteria Escherichia coli. These proteins are known to be linked to the development of Alzheimer's disease, though the cause of the disease is still unknown [1]. They are both found in the brain in and around our neurons, and during Alzheimer's disease they accumulate to form plaques and tangles [2, 3]. Because these proteins are prone to misfolding and aggregate they are hard to study in a laboratory environment, which has slowed down research. It’s here our project comes in, trying to facilitate the production of these proteins.
+
Amyloid-Beta and Tau are proteins which are known to be linked to the development of Alzheimer's disease, though the cause of the disease is still unknown [1]. They are both found in the brain in and around our neurons, and during Alzheimer's disease they accumulate to form plaques and tangles [2, 3]. The study of these aggregates are often done by staining them(4), which in turn demands an amount of the plaques great enough for staining. To instead study the early development of the aggregates a new method has to be developed. This could be studied by fusing a fluorescent markers like Green Fluorescent Protein (GFP) with the aggregation prone proteins. The problem is that when these marker are combined with the aggregation prone protein they become hard to express in Escherichia coli [5]. <u>Therefore this year’s project is to optimize the expression the fusion proteins containing a fluorescent marker and amyloid-beta or tau in E. Coli. </u>
 
+
</br></br>
<!-- Text from the next section, to get a better side list -->
+
To optimize the expression of the proteins we will be using overexpressed chaperones. Chaperones are proteins that can help other proteins to fold into their native three-dimensional shape, for example by dissolving aggregates and guiding both unfolded and misfolded proteins to their correctly folded form [6]. During our project we will be using four different chaperones and we will see how different combinations of these affect the expression of Amyloid-beta and Tau respectively.
<br><br>
+
To optimize the expression of the proteins we will be using chaperones. Chaperones are proteins that can help other proteins to fold into their native three-dimensional shape, by dissolving aggregates and guiding both unfolded and misfolded proteins to their correctly folded form. During our project we will be using four different chaperones and we will see how different combinations of these affect the expression of Amyloid-beta and Tau respectively.
+
 
</p>
 
</p>
 
</article>
 
</article>
Line 40: Line 38:
 
<li>The cause of Alzheimer’s disease is formation of protein accumulations in the brain.</li>
 
<li>The cause of Alzheimer’s disease is formation of protein accumulations in the brain.</li>
 
<li>Alzheimer’s disease is a fatal disease.</li>
 
<li>Alzheimer’s disease is a fatal disease.</li>
 +
<li>Read more <a href="https://2017.igem.org/Team:Linkoping_Sweden/AlzheimersDisease"> here </a> </li>
 
</ul>
 
</ul>
 
</article>
 
</article>
Line 47: Line 46:
 
</div>
 
</div>
 
 
<!--<article class="flex-text-100">
 
<p>
 
To optimize the expression of the proteins we will be using chaperones. Chaperones are proteins that can help other proteins to fold into their native three-dimensional shape, by dissolving aggregates and guiding both unfolded and misfolded proteins to their correctly folded form. During our project we will be using four different chaperones and we will see how different combinations of these affect the expression of Amyloid-beta and Tau respectively.
 
</p>
 
</article>-->
 
 
 
 
<div class="flex-flipper">
 
<div class="flex-flipper">
 
<article class="flex-text-70">
 
<article class="flex-text-70">
 
<p>
 
<p>
The chaperones we will study are GroEL, GroES, DnaK and Trigger factor. GroEL and GroES helps unfolded and misfolded proteins to fold correctly. DnaK helps with disaggregating and with unfolding of misfolded proteins. And Trigger factor helps the protein to remain unfolded during its synthesis.
+
The chaperones we will study are GroEL, GroES, DnaK and Trigger factor. GroEL and GroES helps unfolded and misfolded proteins to fold correctly [7]. DnaK helps with disaggregating and with unfolding of misfolded proteins [6]. And Trigger factor helps the protein to remain unfolded during its synthesis [7].
</br>To express the chaperones in the bacteria we will use a large plasmid containing all four chaperones and give them unique promotors, one for GroEL-GroES, one for DnaK and one for TF. The purpose of this was to easily be able to induce transcription of the specific chaperones in different combinations.  
+
 
 +
</br></br>
 +
To overexpress the chaperones in the bacteria we will use a large plasmid containing all four chaperones and give them unique positively regulated promotors, one for GroEL-GroES, one for DnaK and one for TF. The purpose of this was to easily be able to induce transcription of the specific chaperones in different combinations.  
 
</p>
 
</p>
 
</article>
 
</article>
Line 68: Line 64:
 
<article class="flex-text-70">
 
<article class="flex-text-70">
 
<p>
 
<p>
To measure our expression of these proteins we will fuse them with fluorescent proteins called E-GFP and mNeonGreen. Thereby we can measure the fluorescence to follow the expression of the fusion proteins. For every one of alzheimer - fluorescent fusion protein we will create a plasmid resulting in 4 combinations. These 4 plasmids will use a fourth promotor so that we can control this expression as well.
+
The fluorescent markers we will fuse our proteins with are Enhanced-GFP (EGFP) and mNeonGreen. EGFP are a variation of GFP and mNeonGreen is derived from LanYFP [8]. mNeonGreen itself foldes much faster than EGFP and therefore one of these two could be expressed more easily than the other.
 +
</br></br>
 +
For every one of alzheimer-fluorescent fusion protein we will create a plasmid resulting in 4 combinations. These 4 plasmids will use a fourth promotor so that we can control this expression as well.
 
</p>
 
</p>
 
</article>
 
</article>
Line 76: Line 74:
 
</div>
 
</div>
  
 +
<div class="flex-flipper">
 
                                 <article class="flex-text-100">
 
                                 <article class="flex-text-100">
 
<p>
 
<p>
Line 81: Line 80:
 
</p>
 
</p>
 
</article>
 
</article>
+
</div>
 +
 
 +
<div class="flex-flipper">
 
<article class="flex-text-100">
 
<article class="flex-text-100">
 +
<h3> Our work process </h3>
 
<p>
 
<p>
 
The overview of the project is summarized in figure 1 below. As can be seen in the figure, chaperones and conditions will be tested in a screening process, with the purpose to find the best setup for further detailed studies. The detailed studies will involve modeling with systems biology, where the modeling team will give suggestions on what the laboratory team shall do to achieve the desired task. The flow of data between the laboratory and the modeling team will eventually result in the final data, with is the optimized setup for the expression of our peptides.
 
The overview of the project is summarized in figure 1 below. As can be seen in the figure, chaperones and conditions will be tested in a screening process, with the purpose to find the best setup for further detailed studies. The detailed studies will involve modeling with systems biology, where the modeling team will give suggestions on what the laboratory team shall do to achieve the desired task. The flow of data between the laboratory and the modeling team will eventually result in the final data, with is the optimized setup for the expression of our peptides.
 
</p>
 
</p>
 
</article>
 
</article>
+
</div>
 +
 
 
<div class="flex-img-100">
 
<div class="flex-img-100">
 
<img alt="project flow-chart" class="img-center" src="https://static.igem.org/mediawiki/2017/d/dd/T--Linkoping_Sweden--Flowchart_green.png">
 
<img alt="project flow-chart" class="img-center" src="https://static.igem.org/mediawiki/2017/d/dd/T--Linkoping_Sweden--Flowchart_green.png">
Line 102: Line 105:
 
<p class="text-small">
 
<p class="text-small">
 
1. Alzheimerfonden. Alzheimers sjukdom [Internet]. Cited 2017-06-15. Available from: http://www.alzheimerfonden.se/om_demens/alzheimers_sjukdom [in swedish]
 
1. Alzheimerfonden. Alzheimers sjukdom [Internet]. Cited 2017-06-15. Available from: http://www.alzheimerfonden.se/om_demens/alzheimers_sjukdom [in swedish]
<!--</br> 2. Alzheimer´s Disease International. Dementia statistics [Internet]. Cited 2017-06-27. Available from: https://www.alz.co.uk/research/statistics-->
 
 
</br> 2. Alzheimerfonden. Lexikon för Alzheimers sjukdom och andra demenssjukdomar [Internet]. Cited 2017-06-15. Available from: http://www.alzheimerfonden.se/om_demens/lexikon [in swedish]
 
</br> 2. Alzheimerfonden. Lexikon för Alzheimers sjukdom och andra demenssjukdomar [Internet]. Cited 2017-06-15. Available from: http://www.alzheimerfonden.se/om_demens/lexikon [in swedish]
</br> 3. Bloom GS. Amyloid-β and TauThe Trigger and Bullet in Alzheimer Disease Pathogenesis. JAMA Neurol. 2014;71(4):505-508. doi:10.1001/jamaneurol.2013.5847  
+
</br> 3. Bloom GS. Amyloid-β and TauThe Trigger and Bullet in Alzheimer Disease Pathogenesis. JAMA Neurol. 2014;71(4):505-508. doi:10.1001/jamaneurol.2013.5847
 +
</br> 4. Baltes C, Princz-Kranz F, Rudin M, Mueggler T. Detecting Amyloid-β Plaques in Alzheimer’s Disease BT  - Magnetic Resonance Neuroimaging: Methods and Protocols. In: Modo M, Bulte JWM, editors. Totowa, NJ: Humana Press; 2011. p. 511–33. Available from: https://doi.org/10.1007/978-1-61737-992-5_26
 +
</br> 5. Kim, W., & Hecht, M. H. (2008). Mutations Enhance the Aggregation Propensity of the Alzheimer’s Aβ Peptide. Journal of Molecular Biology. http://doi.org/10.1016/j.jmb.2007.12.079
 +
</br> 6. Schröder, H., Langer, T., Hartl, F. U., & Bukau, B. (1993). DnaK, DnaJ and GrpE form a cellular chaperone machinery capable of repairing heat-induced protein damage. The EMBO Journal, 12(11), 4137–44. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=413706&tool=pmcentrez&rendertype=abstract
 +
</br> 7. Powers, E. T., Powers, D. L., & Gierasch, L. M. (2012). FoldEco: A Model for Proteostasis in E. coli. Cell Reports, 1(3), 265–276. http://doi.org/10.1016/j.celrep.2012.02.011
 +
</br> 8. Shaner, N. C., Lambert, G. G., Chammas, A., Ni, Y., Cranfill, P. J., Baird, M. A., … Wang, J. (2013). A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. Nature Methods, 10(5), 407–409. http://doi.org/10.1038/nmeth.2413
 
</p>
 
</p>
 
</article>
 
</article>

Latest revision as of 13:47, 31 October 2017

Project Description


Amyloid-Beta and Tau are proteins which are known to be linked to the development of Alzheimer's disease, though the cause of the disease is still unknown [1]. They are both found in the brain in and around our neurons, and during Alzheimer's disease they accumulate to form plaques and tangles [2, 3]. The study of these aggregates are often done by staining them(4), which in turn demands an amount of the plaques great enough for staining. To instead study the early development of the aggregates a new method has to be developed. This could be studied by fusing a fluorescent markers like Green Fluorescent Protein (GFP) with the aggregation prone proteins. The problem is that when these marker are combined with the aggregation prone protein they become hard to express in Escherichia coli [5]. Therefore this year’s project is to optimize the expression the fusion proteins containing a fluorescent marker and amyloid-beta or tau in E. Coli.

To optimize the expression of the proteins we will be using overexpressed chaperones. Chaperones are proteins that can help other proteins to fold into their native three-dimensional shape, for example by dissolving aggregates and guiding both unfolded and misfolded proteins to their correctly folded form [6]. During our project we will be using four different chaperones and we will see how different combinations of these affect the expression of Amyloid-beta and Tau respectively.

Quick facts about Alzheimer's disease:


  • Around 60-70 % of people with dementia have Alzheimer’s disease.
  • Around 1 in 100 has Alzheimer’s disease in Sweden.
  • The cause of Alzheimer’s disease is formation of protein accumulations in the brain.
  • Alzheimer’s disease is a fatal disease.
  • Read more here

The chaperones we will study are GroEL, GroES, DnaK and Trigger factor. GroEL and GroES helps unfolded and misfolded proteins to fold correctly [7]. DnaK helps with disaggregating and with unfolding of misfolded proteins [6]. And Trigger factor helps the protein to remain unfolded during its synthesis [7].

To overexpress the chaperones in the bacteria we will use a large plasmid containing all four chaperones and give them unique positively regulated promotors, one for GroEL-GroES, one for DnaK and one for TF. The purpose of this was to easily be able to induce transcription of the specific chaperones in different combinations.

The fluorescent markers we will fuse our proteins with are Enhanced-GFP (EGFP) and mNeonGreen. EGFP are a variation of GFP and mNeonGreen is derived from LanYFP [8]. mNeonGreen itself foldes much faster than EGFP and therefore one of these two could be expressed more easily than the other.

For every one of alzheimer-fluorescent fusion protein we will create a plasmid resulting in 4 combinations. These 4 plasmids will use a fourth promotor so that we can control this expression as well.

If we succeeds with our project we will create a model for successfully expressing these aggregate prone fusion proteins. The future of the project would then be to apply this model to other troublesome proteins and get a deeper knowledge about how the chaperones handle them.

Our work process

The overview of the project is summarized in figure 1 below. As can be seen in the figure, chaperones and conditions will be tested in a screening process, with the purpose to find the best setup for further detailed studies. The detailed studies will involve modeling with systems biology, where the modeling team will give suggestions on what the laboratory team shall do to achieve the desired task. The flow of data between the laboratory and the modeling team will eventually result in the final data, with is the optimized setup for the expression of our peptides.

project flow-chart

Figure 1. An overviewing design of the project.



Sources

1. Alzheimerfonden. Alzheimers sjukdom [Internet]. Cited 2017-06-15. Available from: http://www.alzheimerfonden.se/om_demens/alzheimers_sjukdom [in swedish]
2. Alzheimerfonden. Lexikon för Alzheimers sjukdom och andra demenssjukdomar [Internet]. Cited 2017-06-15. Available from: http://www.alzheimerfonden.se/om_demens/lexikon [in swedish]
3. Bloom GS. Amyloid-β and TauThe Trigger and Bullet in Alzheimer Disease Pathogenesis. JAMA Neurol. 2014;71(4):505-508. doi:10.1001/jamaneurol.2013.5847
4. Baltes C, Princz-Kranz F, Rudin M, Mueggler T. Detecting Amyloid-β Plaques in Alzheimer’s Disease BT - Magnetic Resonance Neuroimaging: Methods and Protocols. In: Modo M, Bulte JWM, editors. Totowa, NJ: Humana Press; 2011. p. 511–33. Available from: https://doi.org/10.1007/978-1-61737-992-5_26
5. Kim, W., & Hecht, M. H. (2008). Mutations Enhance the Aggregation Propensity of the Alzheimer’s Aβ Peptide. Journal of Molecular Biology. http://doi.org/10.1016/j.jmb.2007.12.079
6. Schröder, H., Langer, T., Hartl, F. U., & Bukau, B. (1993). DnaK, DnaJ and GrpE form a cellular chaperone machinery capable of repairing heat-induced protein damage. The EMBO Journal, 12(11), 4137–44. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=413706&tool=pmcentrez&rendertype=abstract
7. Powers, E. T., Powers, D. L., & Gierasch, L. M. (2012). FoldEco: A Model for Proteostasis in E. coli. Cell Reports, 1(3), 265–276. http://doi.org/10.1016/j.celrep.2012.02.011
8. Shaner, N. C., Lambert, G. G., Chammas, A., Ni, Y., Cranfill, P. J., Baird, M. A., … Wang, J. (2013). A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. Nature Methods, 10(5), 407–409. http://doi.org/10.1038/nmeth.2413